NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
Closed Posted
- Opportunity number
- PAR-25-204
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Up to $350,000
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Categories
-
- Education
- Health
- Eligible applicants
-
- Small Businesses
- City/Township Governments
- 501(c)(3) Nonprofits
- For Profit Organizations
- State Governments
- Public or Indian Housing Auth.
- Tribal Governments (Federally Recognized)
- Special District Governments
- Independent School Districts
- Non-501(c)(3) Nonprofits
- County Governments
- Tribal Organizations (Not Federally Recognized)
- Higher Education Inst. (Private)
- Higher Education Inst. (Public)
- Other
- Points of contact
-
- NIH OER Webmaster grantsinfo@nih.gov
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Institutes of Health is seeking applications for the NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed), with an application due date of August 13, 2026. This mechanism does not support clinical trials or non-research-related clinical training.
Eligible applicants include higher education institutions (public and private), small businesses, nonprofits (501(c)(3) and non-501(c)(3)), tribal governments and tribal organizations, state and local governments, and other entity types. The program supports educational activities that enhance workforce training in substance use and substance use disorder research, targeting individuals in clinically focused careers or those training as clinicians, health service providers, clinical researchers, or combinations thereof.
Awards operate under CFDA 93.279 (Drug Use and Addiction Research Programs) administered by the National Institute on Drug Abuse. Recent awards in this CFDA cluster in the $35,000 to $162,000 range for individual fellowship and early-career investigator grants, while larger mechanisms reach $300,000 to $865,000. Project periods typically do not exceed five years, with non-competing continuations available prior to project termination unless restricted.
The program prioritizes scientific and technical merit, research feasibility, potential contribution to national drug abuse problems, and relevance to NIDA priorities. Peer review occurs through scientific review groups, with final approval and payment authority held by NIDA following National Advisory Council concurrence. The typical timeline from application submission to award is 240 to 270 days.
Synopsis
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIDA R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. This NOFO is intended to support research education activities that enhance the knowledge of substance use and substance use disorder research. The program is intended for those in clinically focused careers and/or those training for careers as clinicians/health service providers, clinical researchers, or optimally a combination of the two. This mechanism may not be used to support non-research-related clinical training.
Files
| File | Type | Posted |
|---|---|---|
| PAR-25-204-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity